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SUMMARY
Transcription factor programming of pluripotent stem cells (PSCs) has emerged as an approach to 
generate human neurons for disease modeling. However, programming schemes produce a variety 
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of cell types, and those neurons that are made often retain an immature phenotype, which limits 
their utility in modeling neuronal processes, including synaptic transmission. We report that 
combining NGN2 programming with SMAD and WNT inhibition generates human patterned 
induced neurons (hpiNs). Single-cell analyses showed that hpiN cultures contained cells along a 
developmental continuum, ranging from poorly differentiated neuronal progenitors to well-
differentiated, excitatory glutamatergic neurons. The most differentiated neurons could be 
identified using a CAMK2A::GFP reporter gene and exhibited greater functionality, including 
NMDAR-mediated synaptic transmission. We conclude that utilizing single-cell and reporter gene 
approaches for selecting successfully programmed cells for study will greatly enhance the utility 
of hpiNs and other programmed neuronal populations in the modeling of nervous system 
disorders.
In Brief
Nehme et al. combine two strong neuralizing factors (transcription factor programming and small 
molecule patterning) to generate human excitatory neurons from stem cells. They further 
undertake single-cell and reporter gene approaches to select highly differentiated neurons with 
increased functionality, augmenting their utility in the modeling of nervous system disorders.
INTRODUCTION
Progress toward producing more accurate in vitro models of human brain cell types 
continues to be made (Brennand et al., 2015; Paşca et al., 2015). Directed differentiation 
approaches aim to mimic embryonic development by stepwise specification of neuronal 
subtypes (Chambers et al., 2009; Espuny-Camacho et al., 2013; Zhang et al., 2013; Ho et al., 
2015). In one such strategy, pluripotent stem cells (PSCs) can be neuralized through the 
inhibition of bone morphogenetic protein (BMP) and transforming growth factor β (TGF-β) 
signaling (Chambers et al., 2009; Maroof et al., 2013), regionally specified with 
morphogens, and then allowed to differentiate. While this approach enables cells to transit 
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through cellular states normally observed during embryogenesis, differentiation unfolds 
slowly. Generation of early post-mitotic forebrain neurons can take as long as 5 weeks, 
while the production of astrocytes or oligodendrocytes requires even more extended times in 
culture (Tao and Zhang, 2016).
In contrast, transcription factor-programming approaches rely on ectopic expression of 
lineage-specific transcription factor(s), in either somatic cells or PSCs, to achieve a rapid 
cell fate conversion (Son et al., 2011; Mertens et al., 2016). It has been shown that Ascl1, 
Brn2, and Myt1l can convert mouse fibroblasts into induced neurons (iNs) in as little as 2 
weeks (Vierbuchen et al., 2010). More recently, expression of the neuralizing transcription 
factor NGN2 in human PSCs (hPSCs) was reported to induce an excitatory neuronal identity 
in a similar time frame (Zhang et al., 2013). While these methods allow more rapid 
production of human neurons, insight into the heterogeneity of differentiated neurons 
remains limited. Indeed, using single-cell analysis, it was revealed that, in addition to 
producing iNs, ASCL1-mediated programming also generated muscle cells (Treutlein et al., 
2016). Uncertainty surrounding the identity of iN populations raises concerns that 
programming methods might not produce cells with strong relevance for disease studies.
Cell types made by directed differentiation and programming also share the limitation that 
they display relatively immature transcriptional phenotypes. For instance, neurons produced 
by directed differentiation of induced pluripotent stem cells (iPSCs) derived from patients 
with schizophrenia most resembled human fetal tissue (Brennand et al., 2015). Accordingly, 
stem cell-derived neurons also displayed immature physiological and synaptic phenotypes. 
For example, while AMPA receptor (AMPAR)-mediated synaptic transmission was robust in 
NGN2-programmed iNs, only limited expression of N-Methyl-D-aspartate receptors 
(NMDARs), indicative of a more mature state, was detected (Zhang et al., 2013). Increased 
NMDAR expression has routinely been observed only at very late stages of differentiation 
(up to 145 days in culture) (Gupta et al., 2013; Kirwan et al., 2015). Generation of stem cell-
derived neurons with robust NMDAR-mediated synaptic transmission would have specific 
translational value, as variants in and around the glutamate ionotropic receptor NMDA type 
subunits 2A and 2B (GRIN2A and GRIN2B) have been implicated in epilepsy, intellectual 
disability, autism, and schizophrenia (Schizophrenia Working Group of the Psychiatric 
Genomics Consortium, 2014; Epi, 2015; Sanders et al., 2015). Improved approaches for 
generating and identifying neurons with specific and more differentiated phenotypes from 
PSCs are therefore needed.
Here we tested the utility of combining aspects of directed differentiation and transcription 
factor reprogramming. We then performed population and single-cell RNA sequencing, as 
well as electrophysiological recordings, to understand the properties of the resulting cells. 
Adding extrinsic neuronal patterning to PSCs expressing NGN2 led to more effective 
neutralization, resulting in cells that expressed transcription factors expressed in superficial 
levels of the cortex. Although these cultures were homogenously neuralized, cells existed in 
transcriptional states that ranged from early progenitor to well-differentiated excitatory 
neuron states. More differentiated cells expressing AMPAR and NMDAR subunits also 
expressed CAMK2A, allowing them to be identified using a CAMK2A::GFP reporter gene. 
This approach allowed the isolation of highly differentiated and synaptically active human 
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patterned induced neurons (hpiNs), underscoring the potential utility of this approach for 
modeling diseases associated with glutamate receptor dysfunction, including schizophrenia, 
epilepsy, and autism (Yamamoto et al., 2015; Yuan et al., 2015).
RESULTS
Patterning of NGN2-Induced hPSCs with Dual SMAD and WNT Inhibition
Previously, it has been shown that forced expression of the NGN2 transcription factor in 
hPSCs can induce rapid differentiation into cells with excitable membranes and capable of 
synaptic function (Zhang et al., 2013). We set out to investigate whether the extrinsic 
influences of small molecules that inhibit BMP and TGF-β signaling (Chambers et al., 2009; 
Maroof et al., 2013) could favorably synergize with the activities of NGN2 (Figure 1). To 
this end, NGN2 expression was induced in TetO-NGN2-T2A-PURO/TetO-GFP lentivirally 
infected human stem cells by exposure to doxycycline (dox) 1 day after plating. To induce 
patterning toward a forebrain phenotype, cells were neuralized by inhibiting TGF-β and 
BMP signaling (treatment with SB431542 and LDN193189), and they were dorsalized by 
inhibiting Wnt signaling (treatment with XAV939, a tankyrase inhibitor) for 3 days. 
Puromycin was then applied to select for cells expressing NGN2. The differentiation scheme 
was performed on both hESC (human embryonic stem cell) and hiPSC lines generated from 
fibroblasts of healthy individuals (iPS1 and iPS2). At 4 days post-dox induction (day 4), 
cells were co-cultured with mouse astrocytes to promote neuronal maturation and synaptic 
connectivity (Pfrieger, 2009; Eroglu and Barres, 2010). Consistent with previous 
observations (Zhang et al., 2013), changes in cell shape were evident by day 4, with PSCs 
becoming more polarized and eventually adopting a clear neuronal morphology (Figure 1A).
To examine genome-wide transcriptional changes occurring throughout the differentiation 
process, we performed population RNA sequencing from two individual hiPSC lines (nine 
time points, from undifferentiated stem cells until day 49 of induction) (Figure 1A; Table 
S5). Principal-component analysis (PCA) indicated that, overall, cells clustered along the 
two principal components according to the extent of time since dox induction, with one 
cluster comprising days 2–4 and a second cluster encompassing days 14–49. As 
demonstrated by the tight clustering of biological replicates, these findings were highly 
reproducible across runs of differentiation and cell lines (Figure 1B). Consistent with NGN2 
programming generating predominately excitatory neurons, genes involved in glutamate 
receptor signaling increased in expression in the differentiated cells over time. This was 
particularly evident in the case of AMPAR subunits (Figure S3C).
Inhibition of SMAD and WNT signaling is known to pattern cultured neurons toward a 
forebrain identity (Chambers et al., 2009; Maroof et al., 2013). Consistent with previous 
findings, we failed to detect in the hpiNs expression of genes specific for other lineages, 
such as spinal motor neurons, hindbrain, MGE/inhibitory neurons, as well as hypothalamic, 
diencephalic, hippocampal, and dopaminergic markers (Table S1).
To further investigate the effect of small molecule patterning on the iNs, we compared the 
expression of pluripotency and neuronal progenitor genes by qPCR in day 4 cells that had 
been subjected to either no small molecule treatment, dual SMAD inhibition (the addition of 
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SB431542 and LDN193189), or dual SMAD and WNT inhibition (the addition of 
SB431542, LDN193189, and XAV939) in conjunction with NGN2 overexpression. We 
found that combining dual SMAD and WNT inhibition with NGN2 induction significantly 
improved several aspects of differentiation relative to NGN2 expression alone. These 
included downregulation of the pluripotency gene OCT4, in addition to significant 
upregulation of genes expressed in forebrain progenitors, such as EMX1, OTX1, OTX2, 
FOXG1, and PAX6 (Figure S2E).
We next compared the human BrainSpan dataset, where different human brain areas were 
transcriptionally profiled over a large developmental window (Brainspan, 2011; Miller et al., 
2014), with our population RNA sequencing time course of hpiN differentiation. Pearson 
correlation between expression data from the brain samples and hpiNs revealed that most 
profiles of the in vitro-derived neurons correlated strongly with the prenatal cortex. Notably, 
at later stages of in vitro differentiation, correlations with human postnatal and even adult 
stages began to emerge, most prominently in day 49 hpiNs (Figure 1C). Collectively, our 
initial findings suggest that NGN2 induction synergized well with dual SMAD and WNT 
inhibition to improve differentiation, resulting in a population of neurons expressing gene 
products commonly observed in excitatory neurons of the mouse and human cortices, but 
not factors selectively expressed in other notable brain regions. Furthermore, we found that 
hpiNs could differentiate sufficiently that at least some molecular features of the postnatal 
brain appeared to become present.
Single-Cell qRT-PCR of hpiN Differentiation
To better understand the heterogeneity of differentiating hpiNs, we next turned to single-cell 
methods for measuring gene expression. Initially, we designed a Fluidigm Biomark Chip for 
single-cell qRT-PCR with 96 gene-specific probes (Table S2). Each human gene to be 
measured was selected by orthology with genes previously found to be expressed during 
discrete developmental epochs of mouse brain development or in select progenitor, glia, or 
post-mitotic cortical neuronal subtypes (Miller et al., 2014). We rationalized that analyzing 
the combinatorial expression of these 96 genes in hpiNs would help us to identify the class-
specific identity of each differentiating cell (Arlotta et al., 2005; Ip et al., 2010; Saito et al., 
2011). To this end, we performed single-cell sorting to harvest individual hpiNs into 96-well 
plates at several time points (days 0, 4, 14, and 21; Table S5). The transcriptional signature 
of each cell was then determined using the 96 gene probes described above.
As an initial approach to characterizing the heterogeneity of gene expression among the cells 
analyzed, we performed PCA, and we found that the first principal component (PC1) 
accounted for approximately a third of the total variation (27%) in the dataset and could be 
best explained by the extent of cellular differentiation that had occurred in each cell (Figure 
S1C). Less differentiated cells clustered together and separately from more differentiated 
cells (Figure S2A). Subsequent hierarchical clustering of the population structure revealed 
four clusters that corresponded to three distinct differentiation states (Figures 1D and S1D). 
The first group of cells expressed genes uniquely active in hPSCs and was composed 
primarily of day 0 stem cells (n = 100 cells). The second group was composed of cells 
expressing gene products found in developing brain-progenitor populations, as well as lower 
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abundances of transcripts expressed in many neuronal types. We found that this second 
cluster was mostly populated by day 4 cells, but also by a subset of cells at day 14 and day 
21 of differentiation (n = 216 cells in total). The final group comprised more differentiated 
cells harvested at later time points (day 14 and day 21, n = 143 cells in total), and it 
contained a greater abundance of transcripts commonly found in differentiated neurons 
(Figures 1D, S1C, and S1D). At day 21, the latest time point we initially analyzed, we found 
that 45% of hpiNs fell within the second cluster of apparent progenitors, while 55% of cells 
appeared to have become more differentiated neuronal cells (third cluster).
We next compared the expression of specific groups of genes between cells harvested at day 
0 and day 21. Density plots showed a decrease of pluripotency and progenitor genes in day 
21 hpiNs relative to day 0 cells (Figures 1D and 1E). Conversely, pan-neuronal gene 
expression was increased (Figure 1E; Table S3). In agreement with our population RNA 
sequencing data, transcripts expressed in mouse upper layer cortical projection neurons were 
increased in their abundance, while transcripts found in deep layer mouse cortical neurons 
were not enriched in day 21 hpiNs (Figures 1E and S1F). Strikingly, DCX, MAP2, and 
NEUN expression significantly increased up through day 14, indicating that significant 
neuronal differentiation was already occurring between day 4 and day 14 (Figure S1F). 
Furthermore, hpiNs did not express significant levels of inhibitory neuron markers or glial 
markers at any time point during differentiation (Figures 1D and 1E). These results were 
reproducible across an independent cell line (iPS2) (Figures S2A and S2B; n = 660 cells). 
Finally, to validate the single-cell Fluidigm results at the protein level, we examined the 
expression of a subset of these gene products by immunostaining. We confirmed the 
expression of transcription factors expressed in upper layer cortical projection neurons of the 
mouse, such as CUX1, CUX2, and BRN2, but not markers expressed in the deep layers, 
such as CTIP2 (Figures S1A and S1B). Taken together, these results suggested that the iNs 
were homogeneously patterned but were heterogenous with respect to the extent of their 
differentiation.
Comparison between Transcriptional Profiles of Progenitors and Differentiated Neurons
When we examined individual genes, we noted that a subset of progenitor markers remained 
expressed in day 21 hpiNs (Figures 1D, 1E, and S1F). Intrigued by the persistence of 
progenitor features as well as the emergence of mature features in the more differentiated 
neuronal population, we designed a second Fluidigm Biomark Chip (chip 2) with genes 
associated with cortical glutamatergic neurons, as well as neurochemical and synaptic 
markers (Table S2). We then profiled single neurons differentiated for 14, 21, and 28 days 
(511 cells analyzed in total; Table S5). PCA and hierarchical clustering of gene expression 
data confirmed that differentiation state was the main driver segregating the clusters (Figures 
1F and 1G). In particular, cells segregated into two main clusters, which were classified as 
progenitor/early post-mitotic and differentiated based on the PC loadings. However, each 
cluster contained cells from each of the time points, suggesting that some progenitors did not 
transition toward a more differentiated state over time.
We next assessed the reproducibility of the hpiN differentiation scheme among three human 
iPSC lines (iPS1, iPS2, and iPS3) and one hECS line (ES1), as well as across biological 
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replicates (n = 891 cells examined; Figure S2; Table S2), and we found highly similar 
patterning (Figures S2C and S2D). Furthermore, PCA indicated that, regardless of whether 
small molecule patterning was added to NGN2 programming or the length of time that dox 
induction was applied, a population of neuronal progenitors that seemed resistant to further 
differentiation remained present (Figures S2F–S2H).
Using our Fluidigm datasets, we next performed differential gene expression analysis to 
identify candidate marker genes for the most molecularly differentiated neurons. The top 
differentially expressed genes between progenitors and more differentiated neurons were 
known pan-neuronal markers, such as MAP2, MAPT, and NEUN, or synaptic markers, 
including SYN1, DLG4, GPHN, and CAMK2A (Figure 1H). Upon closer examination, we 
found that GRIA1, GRIA4, NEUN, and CAMK2A expression appeared to be present in the 
differentiated cluster but nearly or completely absent in the progenitor cluster. Of these, 
NEUN is a commonly used neuronal marker, but, given that it is a nuclear protein, it did not 
meet our criteria as a marker with potential for isolation of differentiated neurons. After 
canvassing the literature for any known role in postnatal mouse brain and mature synaptic 
function for the candidates on our gene list, CAMK2A stood out because of its well-known 
expression at postnatal stages in mouse (Lein et al., 2007). Camk2a-GFP mice have also 
been used to identify postnatal, post-mitotic glutamatergic neurons in rodents (Lein et al., 
2007; Wang et al., 2013), as well as mature forebrain neurons (Shcheglovitov et al., 2013). 
Encouraged by these connections, we queried CAMK2A expression during human brain 
development in the BrainSpan dataset (Miller et al., 2014), and we found that its expression 
increased markedly after birth.
Single-Cell Molecular Analysis of CAMK2A-Expressing hpiNs
To investigate whether CAMK2A expression could serve as a useful marker for the more 
differentiated hpiNs, we transduced the cells with a lentivirus expressing GFP under the 
control of the CAMK2A promoter. We then assayed the expression of the Fluidigm chip 2 
probe set (Table S2) in day 28 hpiNs. Single cells were either sorted for CAMK2A::GFP 
expression (81 cells) or TetO-GFP (161 cells); the TetO-GFP cells were then 
computationally sorted for the expression of CAMK2A (242 cells analyzed in total; Figure 
2A; Table S5). RNA sequencing at day 28 post-dox induction revealed that 52% of hpiNs 
expressed endogenous CAMK2A (fragments per kilobase of transcript per million mapped 
reads [FPKM] > 0), while 20%–30% of the counted cells expressed CAMK2A-GFP. Nearly 
all CAMK2A::GFP-sorted cells expressed endogenous CAMK2A, validating that the 
CAMK2A::GFP construct was accurately reporting on endogenous CAMK2A expression 
(92%) (Figure S3D). When we compared the molecular profile of these three categories of 
cells, PCA and differential gene expression analysis showed that the CAMK2A+ cells 
expressed higher levels of pan-neuronal and synaptic genes compared to the CAMK2A− 
cells. This was true both for cells sorted computationally based on their endogenous 
expression of CAMK2A (CAMK2A+) and cells isolated by flow cytometry using the 
CAMK2A::GFP reporter (Figures 2B and 2C).
We next carried out single-cell RNA sequencing on the same populations following the 
Smart-seq2 protocol (Picelli et al., 2013, 2014). Because of the implication of NMDAR in 
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various disorders of the nervous system, we examined the expression of NMDAR subunits 
GRIN2A and GRIN2B, as well as the AMPAR subunits GRIA1, 2, 3, and 4 in the iNs by 
single-cell qPCR (n = 242 cells) as well as single-cell RNA sequencing (RNA-seq) (n = 93 
cells) (Figures 2D–2F). We found that GRIN2B was robustly expressed in most CAMK2A+ 
cells at day 28 (83% of the cells, with an FPKM > 1). Conversely, GRIN2A was expressed 
in most cells at relatively low levels (95% of cells, with an FPKM > 0), and it was expressed 
in only a subset of the cells at higher levels (22% of the cells, with an FPKM > 1) (Figures 
2D and 2E). We then compared these expression profiles to their developmental expression 
in the human cerebral cortex (http://www.brainspan.org; Miller et al., 2014) (Figure S3A). 
Consistent with previous reports (Traynelis et al., 2010), we found that GRIN2B expression 
was detected in the human cerebral cortex in prenatal stages, with some persisting 
expression into the postnatal stages. GRIN2A, on the other hand, was detected almost 
exclusively in postnatal stages.
Moreover, by comparing hpiNs with hpiNs produced without dual SMAD and WNT 
inhibition, we found that, in both hiPSC lines examined, the expression of the NMDAR 
subunit GRIN2B was significantly higher in neurons generated in the presence of patterning 
small molecules (Figure S2I). This suggests that patterning combined with NGN2 induction 
can synergize to promote expression of NMDAR subunits.
To gain a deeper understanding of how similar hpiNs are to in vivo cell types, we then 
compared their expression profiles to a publicly available dataset of single-cell RNA-seq of 
the developing cortex (Pollen et al., 2014). We found that, while unsorted hpiNs contributed 
to both neuronal and non-neuronal clusters (such as neural progenitor cells [NPCs]), 
CAMK2A+ hpiNs most closely resembled neurons (Figures 3A and 3B). Next, we 
compared hpiN transcriptional profiles to a second reference dataset, which included RNA-
seq of several cell types isolated from adults, in addition to embryonic cell types (Darmanis 
et al., 2015). Consistent with our previous results, we found that unsorted hpiNs clustered 
closely with neurons and other cell types present in the brain. However, CAMK2A+ hpiNs 
clustered with both fetal and adult neurons in the reference dataset (Figures 3C and 3D). 
These analyses validated the utility of the CAMK2A::GFP reporter in demarcating the 
neuronal population, and the identification of more differentiated neurons.
Network Activity of hpiNs as a Function of Neuronal Differentiation
We next set out to comprehensively investigate the functional properties of hpiNs. We first 
used multielectrode arrays (MEAs) to monitor differentiation of stem cells into functional 
neurons at a population level and over time. To this end, we seeded hPSCs on 8 × 8 MEA 
grids, each with 64 microelectrodes, in the absence and presence of mouse glia (Table S5). 
The example raster plots, which provide a graphical representation of extracellular action 
potential trains, showed sparse spiking as early as day 7 (Figure 4A). The spike rate then 
continued to increase throughout the 42-day recording period (Figure S4A). Notably, co-
culturing hpiNs with glia led to significantly higher spiking rates (day 10 onward; Figures 
4A, 4B, S4A, and S4B) and the development of pronounced MEA-wide/global bursts that 
were indicative of neuronal connectivity, between days 14 and 21 (Figure 4A). Overall, we 
found that half of the electrodes were functional by 12.5 when cultured with hpiNs and glia 
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(Figures 4D and S4D). Two additional cell lines (iPS2 and ES1) characterized in this study 
both matured at a comparable rate, illustrating the reproducibility of activity achieved with 
this method (Figures S4C and S4D).
A Physiologically Functional Synaptic Network
Previous studies have suggested that much of the activity found in neurons produced with 
NGN2 expression is mediated through AMPARs (Zhang et al., 2013). Consistent with this 
notion, we observed that application of the AMPAR competitive antagonist NBQX (2,3-
dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione) attenuated spontaneous 
spiking rates and blocked the occurrence of network-wide bursts (Figures 4H and S4E) 
compared to the vehicle (Figures 4F, S4E, and S4F). A complete blockade of the residual 
activity by tetrodotoxin (Figures S4H and S4I), a voltage-gated sodium channel blocker, 
confirmed that these spikes were extracellular action potentials dependent on the activity of 
sodium-gated calcium channels. The AMPAR-independent spikes were likely to be 
occurring due to spontaneous activity in a few residual neurons.
We next wondered whether network effects could also be NMDAR mediated. Indeed, 
application of the NMDAR-selective competitive antagonist D-AP5 significantly reduced 
spike rate and reduced the occurrence of network-wide bursts (Figures 4E, 4I, and S4Eiv). 
Reduction of the spike rate by an NMDA antagonist is direct evidence for surface expression 
of functional NMDARs in the hpiNs and their contribution to the generation of spontaneous 
neuronal activity. Notably, while NMDAR antagonism reduced the spike rate and burst 
activity of the neurons, it had no significant effect on the number of spikes within the 
network bursts (data not shown). In contrast, application of GABAA receptor antagonist 
picrotoxin did not significantly affect firing rates (Figures 4G and S4Eii) or the occurrence 
of network-wide bursts. Thus, GABAA receptor-mediated synaptic transmission did not 
contribute significantly to the synaptic transmission in the iNs. Taken together, these results 
confirmed our conclusions from transcriptional profiling, and they demonstrated that both 
AMPARs and NMDARs mediate excitatory synaptic transmission in hpiNs.
CAMK2A Expression Demarcates hpiNs with More Mature Electrophysiological Properties
To investigate whether the CAMK2A reporter gene could be used to identify more 
differentiated cells with additional functionalities, we subjected cells with or without 
expression of CAMK2A::GFP to whole-cell patch clamp at different time points (days 14, 
21, and 28; Table S5). Indeed, electrophysiological characterization of GFP+ neurons 
showed more mature membrane properties as compared to neighboring GFP− cells. GFP+ 
neurons showed significantly more negative resting membrane potential (RMP), compared 
to GFP− cells, and also significantly larger membrane capacitance (Figures 5A, S5A, and 
S5B). We next quantified action potential (AP) firing properties by giving step current 
injection in current-clamp mode to elicit APs. We found that GFP+ cells at day 21 post-
differentiation showed significantly more hyperpolarized AP threshold and a trend toward 
increased average spike numbers per pulse, suggesting more mature AP-firing properties 
(Figures 5B and S5C). No significant changes were observed in the AP peak amplitude and 
AP half-width, most likely due to the intrinsic variability of the two AP parameters (Figure 
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S5D). CAMK2A+ neurons reached a steady level of maturation at day 28 when APs 
exhibited mature and homogeneous firing patterns.
We further compared voltage-gated sodium (Na+v) channel and potassium (K+v) channel 
currents between GFP+ cells and GFP− cells. Consistent with the more mature AP-firing 
properties, CAMK2A+ cells showed larger voltage-dependent Na+ and K+ currents than 
those in GFP− cells (Figure 5C).
Membrane Properties and Synaptic Transmission in hpiNs
We next performed whole-cell patch-clamp recording at days 14, 21, 28, and 35. The resting 
membrane potential of GFP+ neurons became increasingly negative over time (Figure S5E), 
reaching statistical significance between days 21 and 28. Moreover, when neurons were 
subjected to 10-mV step depolarization, we detected large peaks of the fast inward Na+ 
current (confirmed by Na+v blocker 1 μM tetrodotoxin [TTX]), followed by long-lasting 
outward K+ currents (confirmed by K+v blocker 10 μM tetraethylammonium chloride 
[TEA]) at day 28. We further quantified AP-firing properties by giving step current injection 
of 20 pA in current-clamp mode to elicit APs. At the first 3 weeks after differentiation, 
neurons were not able to produce multiple APs in response to a prolonged depolarizing 
current step (Figure S5F). However, by day 28 nearly 75% of the cells recorded were 
capable of producing multiple APs or AP trains. Analysis of AP-firing properties 
consistently showed time-dependent maturation, comparable to the temporal expression of 
Na+v and K+v (Figure S5G). Thus, the hpiNs exhibited a steady ongoing process of 
membrane electrical property maturation, in which a pronounced shift in a range of 
electrophysiological parameters occurred between day 21 and day 28 post-differentiation. A 
reproducible electrical maturation pattern was observed across hPSC lines and across 
biological replicates (Table S4). Overall, the parameters of AP quantification along with 
RMP of hpiNs at day 28 to day 35 post-differentiation were comparable to rodent cortical 
neurons at an early postnatal development stage (Spitzer, 1994; Oswald and Reyes, 2008).
Functionality of AMPAR and NMDAR in hpiNs
We next asked whether the synaptic properties of hpiNs reflected the complement of 
synaptic components whose transcription we had detected by RNA-seq. We investigated 
basal synaptic transmission; AMPAR mediated spontaneous excitatory postsynaptic currents 
(sEPSCs) that were AP dependent, and AMPAR mediated miniature EPSCs (mEPSCs) in 
the presence of TTX to block APs. Approximately 5% of cells displayed sEPSCs at day 14. 
We detected a dramatic increase in the percentage of cells showing sEPSCs (85%) at day 28, 
suggesting that the synaptic transmission level peaked between day 14 and day 28 (Figure 
5F). Concordantly, the frequency and amplitude of sEPSCs were higher at day 28 (Figures 
5G and 5H). These spontaneous synaptic activities were blocked by AMPAR antagonist 
NBQX, as well as by TTX (Figures 5D and 5E).
NMDA Receptor-Mediated Currents in CAMK2A+ hpiNs
We next went on to perform pharmacological characterization of NMDA receptor-mediated 
currents in CAMK2A::GFP+ neurons at days 14, 21, 28, and 35. As shown in Figure 5I, the 
evoked EPSCs were blocked by NBQX at both −70- and +40-mV holding potentials. This 
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suggests that the synaptically evoked EPSCs are mainly contributed by the activation of 
AMPAR type, but not NMDA-type glutamate receptors, at day 28. However, when we 
implemented fast, exogenous application of 100 μM NMDA to the hpiNs by pressure 
injection with a Picospritzer, we found that approximately 20% of the cells recorded 
displayed NMDAR-mediated currents at day 21 (Figure 5J). NMDA receptors are found in 
both synaptic and extra-synaptic locations on neurons, and the best-characterized extra-
synaptic NMDA receptors include GRIN1 and GRIN2B subunits. The saturating 
concentration of NMDA-induced current responses was largely blocked by 10 μM CP101, 
606, a GRIN2B subunit-selective NMDA receptor antagonist (Figure 5J). We again observed 
a large shift in electrophysiological properties between day 21 and day 28 neurons: about 
70% of cells exhibited NMDAR-mediated current upon NMDA application at day 28 
(Figure 5K). As shown in Figure 5L, the current density of NMDAR-mediated current was 
significantly enhanced as compared to day 21, suggesting that more functional GRIN2B-
containing NMDARs were expressed in day 21 neurons (in agreement with the high 
expression level of GRIN2B at day 21 and day 28, with a subset of cells displaying GRIN2A 
expression at day 28; Figure 2). Strikingly, these results suggest that CAMK2A expression 
can be used as a tool to isolate a more mature subset of hpiNs capable of NMDAR-mediated 
synaptic transmission. Furthermore, our findings suggest that, while a subset of CAMK2A− 
progenitor cells may not further differentiate, the physiological properties of CAMK2A+ 
cells do continue to mature for some time.
Expression of Disease-Associated Synaptic Genes
Large-scale sequencing studies have shown that mutations in genes whose products function 
in excitatory synapses are enriched in patients with neurodevelopmental diseases (Figure 
6A). For example, as evidenced by exome sequencing studies, mutations in NMDARs are 
enriched in patients with forms of epileptic encephalopathies (Epi, 2015). Similarly, a 
broader set of synaptic genes has been proposed to play a role in autism, again through 
exome sequencing studies (Sanders et al., 2015). Association studies have also implicated 
some of these factors in aspects of schizophrenia and intellectual disability (ID) 
(Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). To explore 
the potential of our hpiN-profiling dataset as a resource for disease-modeling studies, we 
determined the expression of disease-associated genes by total population RNA-seq and in 
single sorted day 28 CAMK2A-expressing hpiNs (Figures 6B and 6C). We found that many 
disease-relevant genes were expressed in the hpiNs and that the expression of numerous 
genes (including AMPAR subunits GRIA1, 2, and 3 and NMDAR subunits GRIN1 and 
GRIN2B) increased over differentiation time.
DISCUSSION
We describe here a rapid and reproducible differentiation scheme that combines aspects of 
NGN2 programming in hPSCs (Zhang et al., 2013) with developmental patterning through 
the inhibition of SMAD and WNT signaling (Chambers et al., 2009; Maroof et al., 2013). 
This approach generated a homogenously patterned population of cells differentiating 
toward a cortical excitatory identity. Their properties included robust expression of AMPARs 
and NMDARs, as well as mature synaptic function. We also provide an extensive minable 
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dataset comprising single-cell and total population RNA-seq libraries. This comprehensive 
resource can be used to determine whether specific genes/disorders can be studied in hpiNs 
and which time point(s) would be most suitable for such studies.
We find that hpiNs express many of the genes associated with an upper layer cortical 
projection neuron identity in mouse and human brains (Lake et al., 2016; Tasic et al., 2016). 
Comparing our population and single-cell transcriptomes with stages of human brain 
development, we find that the hpiN population overall is the most strongly correlated with 
the prenatal brain, with emerging postnatal and adult features in the CAMK2A-expressing 
hpiNs. These characteristics make hpiNs an attractive model system for modeling aspects of 
disorders such as autism or schizophrenia, where layer 3 pyramidal neurons in patients show 
reduced spine density (Lewis et al., 2003). Consistent with previous reports that glial cells 
promote neuronal maturation and synaptic activity (Pfrieger, 2009; Eroglu and Barres, 2010; 
Tang et al., 2013), we found that co-culturing the stem cell-derived neurons with mouse glia 
resulted in an increase in firing, as well as in synchronous activity that was reminiscent of 
bursting activity. This increased activity coincided with an increase in expression of genes 
that are involved in neuronal activity and synaptic connectivity.
Heterogeneity of stem cell-derived cell types plagues most if not all differentiation or 
programming approaches reported to date, and it is a major impediment in their use for 
disease-related studies. Single-cell RNA-seq technologies are now providing important 
insight into the extent of this heterogeneity. Yao et al. (2017) performed clonal analysis in 
differentiating hESCs to map a lineage tree of in vitro brain development. Comparing 
clustered single-cell transcriptomes with mouse and human gene expression data, they found 
that a wide-ranging set of progenitor cells, as well as midbrain/hindbrain and cortical 
subtypes, was present in such cultures (Yao et al., 2017). For direct reprogramming using the 
pioneer factor ASCL1, Treutlein et al., (2016) found that transgene silencing prevented a 
subset of fibroblasts from becoming reprogrammed and that a second population of 
fibroblasts unexpectedly activated a myocyte-like transcriptional program. These findings 
illustrate the strength of single-cell technologies to provide insight into the molecular 
heterogeneity of stem cell-derived populations, as well as the challenges associated with 
harnessing their translational utility.
We found that, although the hpiNs were homogeneously patterned, indicative of a similar 
neuronal identity, they were heterogeneous with respect to their extent of differentiation. 
Notably, we detected the expression of progenitor genes prior to neuronal genes, suggesting 
the presence of a progenitor population. We found that progenitor cells persisted at later time 
points, indicating that extending time in culture may be of limited use for eliminating them. 
The reason behind this heterogeneity is unclear but could be due to differences in NGN2 
expression between cells. By designing a single-cell profiling approach aimed to resolve 
progenitor-like cells from more differentiated hpiNs, we were able to resolve much of this 
heterogeneity. We further identified CAMK2A expression as a marker for the more 
differentiated hpiNs, which we also found had more functional synaptic properties. This 
approach could be generalizable to resolve progenitor subsets from more differentiated 
derivatives with superior functional properties in other differentiation or direct 
reprogramming protocols. Most importantly, our molecular and functional analyses revealed 
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robust expression of NMDAR subunits and NMDAR-mediated synaptic properties in day 28 
hpiNs. NMDAR subunits have been implicated in many neurodevelopmental and psychiatric 
disorders through exome sequencing and association studies (Schizophrenia Working Group 
of the Psychiatric Genomics Consortium, 2014; Epi, 2015). Being able to rapidly generate 
homogeneous populations of cortical neurons that robustly express these receptors will 
greatly facilitate the study of brain disorders.
EXPERIMENTAL PROCEDURES
Differentiation of hpiNs
hPSCs were co-infected with TetO-Ngn2-Puro and TetO-GFP (gift from the Wernig Lab) 
and reverse tetracycline-controlled transactivator (rtTA), and were plated at a density of 
100,000 cells/cm2 with rock inhibitor Y27632 (Stemgent 04-0012). Day 1 cells were 
differentiated in KSR media with 10 μM SB431542 (1614, Tocris), 2 μM XAV939 
(04-00046, Stemgent) and 100 nM LDN-193189 (04-0074, Stemgent) along with 
doxycycline hyclate (2 μg/mL) (maintained for the entire differentiation process, unless 
noted). Day 2 media were 50% KSR+SB/XAV/LDN and 50% N2 supplemented with 
puromycin (5 μg/μL), and differentiation media were as previously described (Maroof et al., 
2013). Day 3, N2 media, day 4, neurobasal media (Gibco) supplemented with B27 (50×, 
Gibco), brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CTNF), and 
glial cell-derived neurotrophic factor (GDNF) (R&D Systems 248-BD/CF, 257-NT/CF, and 
212-GD/CF at 10 ng/mL). When co-cultured with glia, day 4 cells were dissociated with 
accutase and plated at a density of 40,000/cm2 with mouse primary cortical glial cells 
(seeded at 70,000/cm2 glia) on geltrex-coated plates. Primary glial preparations from post-
natal day (P)0–P2 mouse pups were obtained as previously described (Di Giorgio et al., 
2008).
Single-Cell Expression Profiling and Transcriptomics
Cells were dissociated using accutase supplemented with DNase (Worthington Biochemical, 
LK003170). A 100-μm nozzle was used for sorting. Cells were sorted by BD Facs Aria, 20 
psi, 40–100 ev/s into 96-well plates (one cell per well) containing 5 μL lysis buffer. For 
Fluidigm Biomark, cells were single-cell sorted into 5 μL of 10 mM Tris (pH 8.0), 0.1 mM 
EDTA supplemented with SUPERase•In (0.1 U/μL final, Ambion, AM2696), and 0.5% 
NP40 (Thermo Scientific, PI-28324). For Smart-seq2 library prep, cells were single-cell 
sorted into 5 μL 1×TCL buffer (QIAGEN, 1031576). After sorting, plates were immediately 
sealed, spun down for 5 min at 550 × g, and flash frozen on dry ice. Sorted cells were then 
stored at −80°C. Details on single-cell expression profiling and transcriptomics analysis are 
provided in the Supplemental Experimental Procedures. To compare the piN cells to 
publicly available single-cell reference datasets (Pollen et al., 2014, Darmanis et al., 2015), 
we performed integrated analysis using Seurat version (v.)2.1
Statistics
qPCR—Multiple comparison ordinary one-way ANOVA was performed with Prism 6 
(GraphPad, La Jolla, CA, USA).
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Single-Cell Expression—Analysis of data and visualization of results were performed 
using Python packages (Numpy 1.7.1, Pandas 0.12.0, SciPy 0.12.0, and Matplotlib 1.2.1) 
and R statistical software (3.2.3).
MEA—All descriptive statistics and statistical tests were performed in MATLAB 
environment (v.8.3, R2014a, MathWorks), using the Statistics Toolbox (v.9.0, R2014a, 
MathWorks). Additional details are provided in the Supplemental Experimental Procedures.
Institutional Permissions—iPS1 and iPS2 were generated from fibroblasts collected in 
Umea, Sweden (SW7388, female, 76 years old and SW510926, male, 51 years old) from 3-
mm forearm dermal biopsies following informed consent under protocols approved by the 
Broad Institute, Harvard University, and Umea University.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Coupling NGN2 expression and SMAD/WNT inhibition yields human 
patterned induced neurons (hpiNs)
• Single-cell analysis indicates excitatory, neuronal identity, with variable 
maturity
• A CAMK2A::GFP reporter gene isolates more differentiated neurons from 
progenitors
• CAMK2A+ hpiNs display AMPAR- and NMDAR-mediated synaptic 
transmission
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Figure 1. Differentiation over Time in Culture
(A) Schematic of hpiN protocol with representative images. NGN2-overexpressing hPSCs 
are treated with dual SMAD and WNT inhibitors over 3 days, then co-cultured with mouse 
astrocytes and differentiated into neurons. Scale bar, 10 μm.
(B) PCA of population RNA-seq data over 49 days of differentiation. Three main clusters 
were observed: pluripotent cells, progenitors, and differentiated neurons.
(C) Pearson’s correlation of the population RNA-seq of hpiNs over time with cortical 
structures of the developing human brain.
(D) Representative heatmap of single-cell Fluidigm Biomark gene expression data at days 0, 
4, 14, and 21 (93 cells at day 0, 51 cells at day 4, 76 cells at day 14, and 239 cells at day 21) 
(chip1).
(E) Density plots. Expression of class-specific genes at day 0 (gray) and day 21 (blue) is 
shown.
(F) PCA of hpiNs harvested at day 14, day 21, or day 28 after induction.
(G) Hierarchical clustering (HC) showing that cells from all time points separate into two 
main clusters, differentiated neurons and progenitor/early post-mitotic cells.
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(H) Differential gene expression analysis between the more differentiated and less 
differentiated neurons based on the clusters in (B). CAMK2A is one of the differentially 
expressed genes between the two groups.
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Figure 2. CAMK2A as a Marker of the More Differentiated Population
(A) Schematic describing the isolation of CAMK2A+ cells, either computationally or with a 
GFP reporter.
(B) PCA of CAMK2A+ and CAMK2A− cells harvested at day 28.
(C) Violin plots of genes differentially expressed in CAMK2A+ and CAMK2A− cells.
(D and E) Violin plots and scatterplots showing the expression of GRIN2A and GRIN2B 
over time in hpiNs and CAMK2A+ neurons at day 28, both detected by single-cell Fluidigm 
Biomark (D) and by single-cell RNA-seq (E).
(F) Violin plots and scatterplots showing the expression of the AMPAR subunits in single 
cells at day 28.
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Figure 3. CAMK2A+ hpiNs Resemble Fetal and Adult Neurons
(A and B) Comparison to Pollen et al., 2014 dataset. The majority of CAMK2A+ hpiNs 
cluster with fetal neurons (GW16-21) in the reference dataset. (A) tSNE labeled by graph-
like clusters and (B) tSNE labeled by cell types.
(C and D) Comparison to Darmanis et al., 2015 dataset. Unsorted cells contribute to 
neuronal and non-neuronal clusters while CAMK2A+ hpiNs cluster with fetal and adult 
neurons in the reference dataset. (C) tSNE labeled by graph-like clusters and (D) tSNE 
labeled by cell types.
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Figure 4. hpiNs Form Active Networks that Are Glutamate Receptor Dependent
Neuronal activity was routinely sampled on MEA plates for 42 days.
(A) Representative raster plots of spontaneous activity. Neurons were cultured in isolation 
(top, green) or with glia co-culture (bottom, orange). Top right insets (green background) 
show spikes detected on 16 electrodes with an expanded 1-s time base (the exploded region 
is both highlighted in and marked by a green arrowhead above the main figure).
(B–E) Network activity of hpiNs. (B) Spike count (mean number of spikes in a 10-s period). 
The activity of neurons derived in isolation (n = 15 cultures from 3 differentiations) is 
compared to those co-cultured with glia (n = 74 cultures from 6 differentiations). (C) 
Proportion of electrodes detecting spontaneous activity, against the number of days post-
induction. For neurons cultured with glia, the data were well fit by a sigmoid function. (D) 
Summary of the A50 from the sigmoid curve fits. The neurons cultured in the absence of 
glia have not been curve fit. (E) Number of burst parameters across conditions; time, time 
base control group that did not receive vehicle or drug (n = 12 cultures from one 
differentiation).
(F–I) Contribution of ionotropic glutamate and GABA receptors to spontaneous activity (at 
day 42) for neurons cultured with glia. Electrode mean spike count (/10 s) recorded over 10 
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min is shown. The solid bar above the plots highlights the addition of vehicle (F, dd.H20, n = 
16 cultures from 3 differentiations) or drug (G, picrotoxin, n = 7 cultures from 2 
differentiations; H, NBQX, n = 7 cultures from 2 differentiations; I, AP5, n = 13 cultures 
from 3 differentiations). (F–Ii) Top significant p values are shown (p values > 0.05 are in 
white, gray indicates that no statistical comparisons have been made). (F–Iii) Mean electrode 
spike counts per electrode recorded during the baseline control period (fourth minute) are 
plotted against the spike count recorded during the test period (ninth minute). The diagonal 
line of equality is plotted in black, and the orange filled circle (and bars) marks the median 
(and Q1–Q3). Plots are split into 4 quadrants; for paired spike counts ≤100 (gray data), the 
ordinate and abscissa are both plot on a linear scale, and when paired spike counts are both 
above 100 they are plot on log-log scale (yellow data). Otherwise data are plot on a mixed 
linear-log/log-linear scale (red and green, respectively). (F–Iiii) Effect of vehicle/antagonist 
application on the number of global bursts is shown. Bursts are analyzed for 2 min at the end 
of the baseline period and for 2 min after drug/vehicle application. Raw data are plotted in 
gray; *p value ≤ 0.05; ns, not significant.
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Figure 5. Time Course Characterization of the Electrophysiological Membrane Properties of 
CAMK2A+ Neurons over Time
(A) Comparison of electrophysiological membrane properties of CAMK2A::GFP+ and 
CAMK2A::GFP− at day 21.
(B) Representative traces of whole-cell voltage-clamp Na+ and K+ currents recorded in a 
GFP+ cell and a GFP− at day 21. Cells were subjected to a 10-mV step depolarizations from 
−110 to +30 mV at a −70-mV holding membrane potential.
(C) Quantification of current/voltage (I/V) curves of Na+ and K+ currents.
(D and E) Representative traces of (D) spontaneous EPSCs and (E) miniature EPSCs in the 
presence of 1 μM TTX at day 28. Lower panel illustrates expansions of selected events.
(F) Percentage of cells exhibiting sEPSCs is significantly increased over time from day 14 to 
day 28.
(G) Quantification of the frequency of sEPSCs shows a significant increase at day 28 as 
compared to day 21.
(H) Quantification of the peak amplitude of sEPSCs recorded at day 21 and day 28.
(I–L) CAMK2A+ neurons mainly express GRIN2B-containing NMDA receptors.
(I) Block of spontaneous EPSCs by 10 μM NBQX at day 28. Representative traces show 
evoked EPSCs measured at a holding membrane potential of −70 mV (left panel) followed 
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by a holding potential of +40 mV at day 28; the evoked EPSCs at both holding membrane 
potentials were blocked by 10 μM NBQX.
(J) Representative traces of whole-cell currents elicited by the application of a saturating 
concentration of NMDA (100 μM). Application duration is indicated by solid bars above 
traces.
(K) Summary of the percentage of neurons that exhibit NMDA receptor-mediated currents at 
day 21 and day 28.
(L) Summary of the NMDAR-mediated current density (pA/pF) at day 21 and day 28. Data 
are means ± SEMs. *p < 0.01, **p < 0.005, and ***p < 0.001, unpaired Student’s t test.
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Figure 6. Expression of Disease-Associated Synaptic Genes in the Derived Neurons
(A) Schematic of a synapse highlighting the synaptic components of interest.
(B) Expression of the disease-associated genes over time based on population RNA-seq data.
(C) Expression of the disease-associated genes in CAMK2A+ single cells (Smart-seq2 data) 
at day 28.
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